Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Carcinogenesis|November 7, 2020
Mutant p53 oncogenicity: dominant-negative or gain-of-function?Yan Stein, Ronit Aloni-Grinstein, Varda RotterJournal of Molecular Cell Biology|July 19, 2019
Mutant p53-a potential player in shaping the tumor-stroma crosstalkYan Stein, Ronit Aloni-Grinstein, Varda RotterInternational Journal of Molecular Sciences|December 11, 2019
Gain-of-Function Mutant p53: All the Roads Lead to TumorigenesisYan Stein, Varda Rotter, Ronit Aloni-GrinsteinCancer Research|February 21, 2013
Dynamics of senescent cell formation and retention revealed by p14ARF induction in the epidermisRonit Tokarsky-Amiel, Narmen Azazmeh, Aharon Helman, et al.Proceedings of the National Academy of Sciences of the United States of America|September 16, 2017
Diverse p53/DNA binding modes expand the repertoire of p53 response elementsPratik Vyas, Itai Beno, Zhiqun Xi, et al.Plos One|May 1, 2013
Mutant p53 attenuates the anti-tumorigenic activity of fibroblasts-secreted interferon betaShalom Madar, Einav Harel, Ido Goldstein, et al.Iscience|July 28, 2026
Interleukin 4-driven loss of stromal LIF signaling affects immune responses and cell-cell adhesion in atopic dermatitisYarden Feller, Kiril Malovitski, Sari Assaf, et al.American Journal of Respiratory and Critical Care Medicine|May 8, 2024
Single-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary FibrosisAvraham Unterman, Amy Y Zhao, Nir Neumark, et al.Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Single-cell profiling reveals immune aberrations in progressive idiopathic pulmonary fibrosisAvraham Unterman, Amy Y Zhao, Nir Neumark, et al.Scientific Reports|July 2, 2016
Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discoveryKristin Stock, Marta F Estrada, Suzana Vidic, et al.Pageof 2